These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7392644)

  • 21. Comparative study of the influence of pregnancy and hormonal treatment on mammary carcinogenesis.
    Russo IH; Koszalka M; Russo J
    Br J Cancer; 1991 Sep; 64(3):481-4. PubMed ID: 1911188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pituitary role in the growth of metastasizing MRMT-1 mammary carcinoma in rats.
    Harada Y
    Cancer Res; 1976 Jan; 36(1):18-22. PubMed ID: 1247997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Possible application of human c-Ha-ras proto-oncogene transgenic rats in a medium-term bioassay model for carcinogens.
    Ohnishi T; Fukamachi K; Ohshima Y; Jiegou X; Ueda S; Iigo M; Takasuka N; Naito A; Fujita K; Matsuoka Y; Izumi K; Tsuda H
    Toxicol Pathol; 2007 Apr; 35(3):436-43. PubMed ID: 17474063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amine-induced cardiac phosphorylase a after reserpine-triiodothyronine pretreatment.
    McNeill JH
    Eur J Pharmacol; 1969 Sep; 7(3):235-8. PubMed ID: 5351983
    [No Abstract]   [Full Text] [Related]  

  • 25. Human chorionic gonadotropin and rat mammary cancer prevention.
    Russo IH; Koszalka M; Russo J
    J Natl Cancer Inst; 1990 Aug; 82(15):1286-9. PubMed ID: 2115592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for a non-calorigenic action of 3,3',5-triiodo L-thyronine on erythropoiesis in reserpine treated rats.
    Bozzini CE; Alippi RM; Perec CJ
    Acta Physiol Lat Am; 1971; 21(1):25-9. PubMed ID: 5153059
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of prepubertal indole-3-carbinol treatment on development of N-methyl-N-nitrosourea-induced mammary carcinomas in female Sprague-Dawley rats.
    Shimano N; Uehara N; Kiyozuka Y; Shikata N; Tsubura A
    In Vivo; 2007; 21(6):983-8. PubMed ID: 18210745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Susceptibility of the mammary gland to carcinogenesis. II. Pregnancy interruption as a risk factor in tumor incidence.
    Russo J; Russo IH
    Am J Pathol; 1980 Aug; 100(2):497-512. PubMed ID: 6773421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Linear relationship between flux density and tumor co-promoting effect of prolonged magnetic field exposure in a breast cancer model.
    Löscher W; Mevissen M
    Cancer Lett; 1995 Sep; 96(2):175-80. PubMed ID: 7585454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NTP Studies of Magnetic Field Promotion (DMBA Initiation) in Female Sprague-Dawley Rats (Whole-body Exposure/Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Aug; 489():1-148. PubMed ID: 12563342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancement and inhibition of the induction by 7,12-dimethylbenz(a)anthracene of mammary tumours in female Sprague-Dawley rats.
    Wheatley DN
    Br J Cancer; 1968 Dec; 22(4):787-97. PubMed ID: 5705143
    [No Abstract]   [Full Text] [Related]  

  • 32. Prolactin binding to mammary gland, 7,12-dimethylbenz(a)-anthracene-induced mammary tumors, and liver in rats.
    Smith RD; Hilf R; Senior AE
    Cancer Res; 1976 Oct; 36(10):3726-31. PubMed ID: 821605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progesterone and the prolonged progestational state: co-carcinogenic factors in mammary tumor induction.
    Poel WE
    Br J Cancer; 1965 Dec; 19(4):824-9. PubMed ID: 5862660
    [No Abstract]   [Full Text] [Related]  

  • 34. Lifetime dose-response relationships for mammary tumor induction by a single administration of N-methyl-N-nitrosourea.
    McCormick DL; Adamowski CB; Fiks A; Moon RC
    Cancer Res; 1981 May; 41(5):1690-4. PubMed ID: 7214338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of high dietary fat on the growth and development of ovarian-independent carcinogen-induced mammary tumors in rats.
    Sylvester PW; Ip C; Ip MM
    Cancer Res; 1986 Feb; 46(2):763-9. PubMed ID: 3079669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of adrenalectomy on the growth of mammary tumours induced by 3-methylcholanthrene in rats.
    Daniel PM; Prichard MM
    Int J Cancer; 1967 Nov; 2(6):619-27. PubMed ID: 5582281
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of 3-methylcholanthrene on thyroid function in Sprague-Dawley rats.
    Newman WC; Moon RC
    Cancer Res; 1966 Sep; 26(9):1938-42. PubMed ID: 5924959
    [No Abstract]   [Full Text] [Related]  

  • 38. Protection by 1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane (DDT) against mammary tumors and leukemia during prolonged feeding of 7,12-dimethylbenz(a)anthracene to female rats.
    Silinskas KC; Okey AB
    J Natl Cancer Inst; 1975 Sep; 55(3):653-7. PubMed ID: 808643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carcinogenic effects of intragastric 3-methylcholanthrene and 7,12-dimethylbenz[a]anthracene in Wistar and Sprague-Dawley rats.
    Gruenstein M; Meranze DR; Thatcher D; Shimkin MB
    J Natl Cancer Inst; 1966 Mar; 36(3):483-95, 497-502. PubMed ID: 18630323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin-like growth factor (IGF)-I obliterates the pregnancy-associated protection against mammary carcinogenesis in rats: evidence that IGF-I enhances cancer progression through estrogen receptor-alpha activation via the mitogen-activated protein kinase pathway.
    Thordarson G; Slusher N; Leong H; Ochoa D; Rajkumar L; Guzman R; Nandi S; Talamantes F
    Breast Cancer Res; 2004; 6(4):R423-36. PubMed ID: 15217511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.